EXCLUSIVE Blackwater founder Prince takes role in COVID vaccine venture

Erik Prince, the founder of controversial private military firm Blackwater and a supporter of former President Donald Trump, jumped into the COVID-19 business late last year with a deal to distribute an experimental vaccine should it be approved, according to three people familiar with the arrangement and business records seen by Reuters.
What you need to know about the coronavirus right now

Here’s what you need to know about the coronavirus right now.
What you need to know about the coronavirus right now

Here’s what you need to know about the coronavirus right now.
Is it all Greek to you? Coronavirus variants get new names

Coronavirus variants with clunky, alphanumeric names have now been assigned the letters of the Greek alphabet to simplify discussion and pronunciation while avoiding stigma.
What you need to know about the coronavirus right now

Here’s what you need to know about the coronavirus right now.
What you need to know about the coronavirus right now

Here’s what you need to know about the coronavirus right now.
What you need to know about the coronavirus right now

Here’s what you need to know about the coronavirus right now.
Buy now, pay later players tackle credit conundrum in Mideast’s Gulf

Financial technology start-ups in Saudi Arabia and the United Arab Emirates offering online short-term credit say they are enjoying exponential growth as the coronavirus pandemic drives a shift in consumer spending online.
More than half of American adults vaccinated as COVID-19 cases ebb

More than half of all adults in the United States have been fully vaccinated against COVID-19, the White House said on Tuesday, roughly six weeks before U.S. President Joe Biden’s July 4 goal of 70% of the adult population receiving at least one shot.
UK competition regulator looking into $39 bln AstraZeneca-Alexion deal

Britain’s competition regulator is reviewing AstraZeneca’s (AZN.L) $39 billion buyout of U.S.-based Alexion (ALXN.O) on concerns it could reduce competition in the UK market or elsewhere.